Newer drugs for focal epilepsy in adults

BMJ (Online)

Volumn 344, Issue 7842, 2012, Pages

  Brodie, Martin J ^a   Kwan, Patrick ^b,c  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ESTROGEN; ETIRACETAM; FOLIC ACID; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ORAL CONTRACEPTIVE AGENT; TRIAZINE DERIVATIVE;

ACNE; ADULT; AGGRESSION; AGITATION; ALOPECIA; ANOREXIA; ANXIETY DISORDER; ATAXIA; BEHAVIOR DISORDER; BLOOD DYSCRASIA; BREAST FEEDING; CASE REPORT; CEREBELLUM ATROPHY; CLINICAL EFFECTIVENESS; CLOSED ANGLE GLAUCOMA; CONFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG CHOICE; DRUG COST; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG MONITORING; DRUG TOLERABILITY; DUPUYTREN CONTRACTURE; ENZYME INDUCTION; ENZYME INHIBITION; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; FETUS ECHOGRAPHY; FOCAL EPILEPSY; FOLIC ACID DEFICIENCY; GINGIVA HYPERPLASIA; HEPATITIS; HIGH RISK PATIENT; HIRSUTISM; HOSTILITY; HUMAN; HYPONATREMIA; INSOMNIA; LETHARGY; MEDICAL HISTORY; MONOTHERAPY; MYOPIA; NAUSEA; NEUROTOXICITY; OPTIMAL DRUG DOSE; OSTEOPOROSIS; PANCREATITIS; PARESTHESIA; PATIENT MONITORING; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PR INTERVAL; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STONE FORMATION; SUICIDAL IDEATION; TERATOGENESIS; TERATOGENICITY; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; TREMOR; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; CONGENITAL MALFORMATION; DRUG ANTAGONISM; DRUG APPROVAL; DRUG COMBINATION; DRUG INTERACTION; MALE; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED KINGDOM;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; CONTRACEPTIVES, ORAL, HORMONAL; DRUG APPROVAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRIAZINES;

EID: 84857767190     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e345     Document Type: Review

References (29)

1. Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med 2011;365:919-26.
2. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure 2010;19:650-5.
3. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
4. Porter RJ, Baulac M, Nohria V. Clinical development of drugs for epilepsy: a review of approaches in the United States and Europe. Epilepsy Res 2010;89:163-75.
5. Costa J, Fareleira F, Ascencao R, Borges M, Sampaio C, Vaz-Carneiro A. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia 2011;52:1280-91.
6. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen HW, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-77.
7. Beyenburg S, Stavem K, Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia 2010;51(1):7-26.
8. Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003;60(11 suppl 4):S2-12.
9. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68:402-8. (Pubitemid 46208740)
10. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15. (Pubitemid 46436124)
11. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-44. (Pubitemid 47063067)
12. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9. (Pubitemid 46763258)
13. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011;10:446-56.
14. Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007;17:413-25. (Pubitemid 350231552)
15. Food and Drug Administration. Information for healthcare professionals: suicidal behavior and ideation and antiepileptic drugs. www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.htm.
16. Andersohn F, Schade R, Willich SN, Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010;75:335-40.
17. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17.
18. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8. (Pubitemid 43220841)
19. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-605.
20. Food and Drug Administration. FDA drug safety communication: risk of oral clefts in children born to mothers taking Topamax (topiramate). www.fda.gov/Drugs/DrugSafety/ucm245085.htm.
21. Hunt S, Craig J, Russell A, Guthrie E, Parsons L, Robertson I, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006;67:1876-9. (Pubitemid 44900776)
22. Dutton C, Foldvary-Schaefer N. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management. Int Rev Neurobiol 2008;83:113-34.
23. Tomson T, Hiilesmaa V. Epilepsy in pregnancy. BMJ 2007;335:769-73. (Pubitemid 47612634)
24. Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, et al. Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;50:1247-55.
25. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-76. (Pubitemid 351991390)
26. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. (Clinical guidance 137.) 2112. http://guidance.nice.org.uk/ CG137.
27. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:401-9. (Pubitemid 38581553)
28. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120. (Pubitemid 44086745)
29. Brodie MJ, Sills GJ. Combining antiepileptic drugs - rational polytherapy? Seizure 2011;20:369-75.